Rediff
Home Mail
NewsBusinessMoviesCricketSportsGetahead
Money HomeNewsForexIndicesMutual FundsInsuranceGainersLosers
TrendsStar PortfoliosMy PortfolioMy Watchlist
BusinessEmailGurusTV
News >
Headlines Defence Images Columns Interviews Specials Coverage Videos Archives
Business >
Headlines Columns Specials Personal Finance Interviews Images Technology Auto Union Budget 2026 Archives
Movies >
Headlines Images Interviews Reviews Web Series Videos South Cinema Quiz Hollywood Archives
Cricket >
Headlines Images Stats Women's T20 WC 2026 WT20 2026: Games, Players, Teams IPL 2026 Archives
Sports >
Headlines Formula 1 Football Tennis Chess Hockey
Get Ahead >
Headlines Specials Careers Glamour Health Achievers Finance Travel Food Videos Gadgets Biking Relationships Archives
Money >
News Forex Indices Sectors Mutual Funds Insurance Gainers Losers Trends Star Portfolios My Portfolio My Watchlist
More
Mail Business Email Gurus TV Rediff Podcast
Top StoriesNewsBusinessCricketMoviesSportsGet ahead
  • Headlines
  • Defence
  • Images
  • Columns
  • Interviews
  • Specials
  • Archives

News for 'Serum Institute of India CEO'

Modi, Mamata, Adar among Time's 100 most influential people

Modi, Mamata, Adar among Time's 100 most influential people

Rediff.com15 Sep 2021

Time's profile of Modi says that in its 74 years as an independent nation, India has had three pivotal leaders -- Jawaharlal Nehru, Indira Gandhi and Modi. "Narendra Modi is the third, dominating the country's politics like no one since them."

DCGI finds no link between Covid vaccine shot and 'adverse' reaction

DCGI finds no link between Covid vaccine shot and 'adverse' reaction

Rediff.com2 Dec 2020

The DCGI arrived at the conclusion on Wednesday based on the recommendations of an independent expert committee which has also opined that compensation should not be paid to the volunteer, they said.

Covovax nod to boost vaccination drive in India: SII

Covovax nod to boost vaccination drive in India: SII

Rediff.com28 Dec 2021

Vaccine major Serum Institute of India on Tuesday said the approval for the COVID-19 vaccine 'Covovax' would strengthen immunization initiatives across India and various lower and middle income countries across the world.

Vaccine drive set in motion, 13 cities get first consignment

Vaccine drive set in motion, 13 cities get first consignment

Rediff.com12 Jan 2021

A massive pan-India inoculation drive against COVID-19 was set in process on Tuesday with more than 56 lakh doses of the Covishield vaccine flown to 13 cities across India from Pune and taken to designated national and state-level stores amid tight security.

'Hope you change your mind': Poonawalla to Djokovic

'Hope you change your mind': Poonawalla to Djokovic

Rediff.com18 Feb 2022

Serum CEO Adar Poonawalla posted a video of him playing tennis, with a message for the unvaccinated Novak Djokovic.

10 things to know about COVID-19 vaccines

10 things to know about COVID-19 vaccines

Rediff.com16 Jan 2021

As India holds its breath for the Covid vaccination to be begin, Sudhir Bisht provides a quick checklist of what you must know about the vaccines that will be administered to citizens.

Global vaccine supply hit due to Covid surge in India:

Global vaccine supply hit due to Covid surge in India:

Rediff.com28 May 2021

The 'terrible' surge of the coronavirus cases in India has severely impacted COVAX's vaccine supply in the second quarter of this year to the extent that there will be a shortfall of 190 million doses by the end of June, according to a joint statement by the WHO, UNICEF, GAVI and CEPI.

'It'll take 3-4 years to vaccinate 80% of population'

'It'll take 3-4 years to vaccinate 80% of population'

Rediff.com11 Jan 2021

'We are hoping by March, the government allows us to export and give it to the private market.'

'We will be prioritising vaccine only for India'

'We will be prioritising vaccine only for India'

Rediff.com14 Apr 2021

'I don't think anybody would want to be in my position today where every head of State has to be explained that I am prioritising my country because there is a surge in cases.'

Why is Karan Johar KISSING Kajol?

Why is Karan Johar KISSING Kajol?

Rediff.com18 Mar 2022

Karan Johar hosted a huge birthday party for Apoorva Mehta, the CEO of Dharma Productions, who turned 50 on March 17.

Sputnik V vaccine may be added to India's Covid armoury soon

Sputnik V vaccine may be added to India's Covid armoury soon

Rediff.com30 Mar 2021

'We expect to get the approval in the next few weeks,' says Deepak Sapra, CEO, API and pharmaceutical services, Dr Reddy's Laboratories (DRL).

Can't ramp up vaccine production overnight: SII's Adar Poonawalla

Can't ramp up vaccine production overnight: SII's Adar Poonawalla

Rediff.com3 May 2021

Poonawalla, who is in London, however, noted that the company is making every effort to enhance production of Covishield amid the second wave of COVID in the country.

Dr Reddy's soft-launches Sputnik V in India at Rs 995 per dose

Dr Reddy's soft-launches Sputnik V in India at Rs 995 per dose

Rediff.com15 May 2021

Dr Reddy's Laboratories on Friday soft-launched imported COVID-19 vaccine Sputnik V, with Deepak Sapra, a senior executive of the drug-maker, taking the first shot in Hyderabad.

Ask parties not to protest amid pandemic: Uddhav to PM

Ask parties not to protest amid pandemic: Uddhav to PM

Rediff.com24 Nov 2020

Speaking during Prime Minister Narendra Modis video conference meeting with chief ministers of eight states which have reported high COVID-19 cases, Thackeray said the PM or Union Home Minister Amit Shah should convene a meeting of all parties to tell them about the seriousness of the situation.

India to produce 850mn Sputnik doses annually: RDIF

India to produce 850mn Sputnik doses annually: RDIF

Rediff.com13 Apr 2021

As per RDIF, Sputnik V has a number of key advantages, including that there are no strong allergies caused by Sputnik V.

Ranbir, Alia join the Kapoors for Christmas brunch

Ranbir, Alia join the Kapoors for Christmas brunch

Rediff.com25 Dec 2020

Ranbir revealed to journalist Rajeev Masand the other day that Alia and he would have gotten married this year, but for the pandemic.

Drones will deliver critical drugs at your doorstep

Drones will deliver critical drugs at your doorstep

Rediff.com17 Sep 2019

Maharashtra govt, California-based Zipline to launch the automated delivery service funded by Serum Institute.

Covid vaccine to be available for every Indian till 2024: Poonawalla

Covid vaccine to be available for every Indian till 2024: Poonawalla

Rediff.com19 Nov 2020

Poonawalla said the price will be around USD 5-6 per dose with an MRP of around Rs 1,000 for the two necessary doses.

Novovax Covid vaccine likely to get nod in India ahead of US

Novovax Covid vaccine likely to get nod in India ahead of US

Rediff.com18 Aug 2021

Adar Poonawalla said he was hopeful that Covovax, the Novavax vaccine made by SII, will be launched around October this year for adults and for children by the first quarter of next year, depending on DCGI approvals.

Covishield to be priced at Rs 400 to states; Rs 600 to pvt hospitals

Covishield to be priced at Rs 400 to states; Rs 600 to pvt hospitals

Rediff.com21 Apr 2021

SII said it will address the limited capacity by scaling up the vaccine production over the next two months.

SIIto test Novavax's Omicron-specific vaccine

SIIto test Novavax's Omicron-specific vaccine

Rediff.com6 Jun 2022

The Drugs Controller General of India has approved the manufacture of this Sars-CoV-2 spike protein recombinant nano-particle vaccine for 'examination, test, and analysis', reports Sohini Das.

Adani adds $49 bn wealth in 2021, higher than Jeff Bezos, Elon Musk

Adani adds $49 bn wealth in 2021, higher than Jeff Bezos, Elon Musk

Rediff.com16 Mar 2022

Gautam Adani, India's and Asia's second-richest person, added $49 billion to his wealth last year - more than the net addition of wealth by the top three global billionaires Elon Musk, Jeff Bezos and Bernard Arnault, the 2022 M3M Hurun Global Rich List said on Wednesday. Mukesh Ambani, who runs the oil-to-retail conglomerate Reliance Industries, continues to be the richest Indian with a wealth of $103 billion, a 24 per cent rise year-on-year. Adani, the head of ports-to-energy conglomerate Adani Group, is a close second with his wealth surging 153 per cent to $81 billion.

India receives 1st consignment of 1.5 lakh Sputnik V vaccine doses from Russia

India receives 1st consignment of 1.5 lakh Sputnik V vaccine doses from Russia

Rediff.com1 May 2021

Sputnik V is the third vaccine India has given the go-ahead to after 'Covishield', developed by Oxford University and AstraZeneca and 'Covaxin', the indigenous vaccine manufactured by Bharat Biotech. Covishield is manufactured by the Serum Institute of India.

What Ivanka will be up to at the Global Entrepreneurship Summit

What Ivanka will be up to at the Global Entrepreneurship Summit

Rediff.com26 Nov 2017

Young Indian entrepreneurs hope to share some of the limelight too at the Hyderabad event.

India may get first Covid-19 vaccine by February

India may get first Covid-19 vaccine by February

Rediff.com30 Nov 2020

The government plans to immunise 30 million people in the first phase, starting February, and by July, the target is to vaccinate 250 million people, reports Sohini Das.

'Budget's focus on 'Bharat' will create jobs'

'Budget's focus on 'Bharat' will create jobs'

Rediff.com1 Feb 2018

'It is a balanced and prudent Budget that sets the foundation for future growth in the economy.'

India has world's 3rd highest number of billionaires; Mukesh Ambani back as Asia's richest

India has world's 3rd highest number of billionaires; Mukesh Ambani back as Asia's richest

Rediff.com7 Apr 2021

India has the third highest number of billionaires in the world after the US and China, according to a new list by the prestigious Forbes magazine, which said Reliance Industries chairman Mukesh Ambani reclaimed his spot as Asia's richest person, dethroning Chinese business tycoon Jack Ma who was the richest person in the region a year ago.

Covid Vaccine: Syringe manufacturers are ramping up

Covid Vaccine: Syringe manufacturers are ramping up

Rediff.com15 Sep 2021

The Centre is looking to procure around 1 billion syringes between September and December to support the COVID-19 vaccination drive.

'Vaccine shortage can't be blamed on Adar Poonawalla'

'Vaccine shortage can't be blamed on Adar Poonawalla'

Rediff.com16 Aug 2021

'It was unfair to expect him to continue to keep on supplying vaccines without being given a firm commitment or a financial grant of any sort.'

Will syringe shortage puncture India's Covid vaccine plans?

Will syringe shortage puncture India's Covid vaccine plans?

Rediff.com14 Oct 2021

Will syringe shortage puncture India's Covid vaccine plans?

COVID-19 vaccine race: Where they stand currently

COVID-19 vaccine race: Where they stand currently

Rediff.com9 Jan 2021

As India prepares to launch its vaccine drive on January 16, here is a look at the options:

Pfizer tells India its vaccine 'highly effective' on Covid variant

Pfizer tells India its vaccine 'highly effective' on Covid variant

Rediff.com26 May 2021

Providing data, it said UK's Public Health England has reported high vaccine effectiveness (87.9 per cent) against the B.1.617.2 variant, most reported in India, in an observational study (concluded on May 22, 2021).

COVID-19 vaccine at least a year away, say scientists

COVID-19 vaccine at least a year away, say scientists

Rediff.com16 Jun 2020

According to the World Health Organisation, 10 candidate vaccines for COVID-19 are in the clinical evaluation and 126 are in the pre-clinical stage.

'I doubt if Sahara is serious about selling properties'

'I doubt if Sahara is serious about selling properties'

Rediff.com30 Jul 2014

Owners of Pune-based Serum Institute of India, the Poonawalla's have thrown the hat to acquire the iconic Grosvenor Hotel in UK from Sahara Group.

Scientists urge caution over launch of Covid vaccine by Aug 15

Scientists urge caution over launch of Covid vaccine by Aug 15

Rediff.com4 Jul 2020

'We must not compromise with the standard, the quality. We don't need to be the first to launch a drug but what we need is a Made in India vaccine that the entire world can rely on'

'We will price Covid vaccine below Rs 1,000'

'We will price Covid vaccine below Rs 1,000'

Rediff.com29 Jul 2020

Pune's Serum Institute of India, the world's largest vaccine maker by volume, is placing its bets on the Oxford-AstraZeneca vaccine candidate AZD1222 with CEO Adar Poonawalla stating he would start manufacturing at personal risk.

Has Modi's Vaccine Diplomacy Failed?

Has Modi's Vaccine Diplomacy Failed?

Rediff.com26 Apr 2021

What is foreign policy worth if it stands disconnected from domestic realities? Make no mistake, the horrifying visuals of the human suffering in metropolitan India is only the tip of the iceberg. The vast swathes of the hinterland are heaving with untold sorrows, notes Ambassador M K Bhadrakumar.

Keeping Govt away from the Covid vaccine

Keeping Govt away from the Covid vaccine

Rediff.com14 Dec 2020

The Indian State has low operational capabilities. Individuals will have concerns about material that flows through the government, on questions of purity, perfection of the cold chain, and correctness of procedures at the frontline. Even if a government programme is able to solve all these problems, it will be limited in scale-up. The passion, management capabilities, and response to local conditions, which will be found with tens of thousands of ground-level initiatives, Individuals will have concerns about material that flows through the government, on questions of purity, perfection of the cold chain, and correctness of procedures. Even if a government programme is able to solve all these problems, it will be limited in scale-up, argues Ajay Shah.

Mukesh Ambani is the world's 10th richest man!

Mukesh Ambani is the world's 10th richest man!

Rediff.com27 Feb 2019

Jeff Bezos of Amazon tops the list for the second consecutive year with networth of $147 billion.

How Indian industry is tapping dengue opportunity

How Indian industry is tapping dengue opportunity

Rediff.com8 Oct 2015

Pharma, insurance and consumer goods companies try to tap the business opportunity

« Prev  |  Next »
Rediff
GET IT ONGoogle Play
GET IT ONApp Store
CONNECT
  • Rediffmail
  • Rediff One
  • - Rediffmail Enterprise
  • - Rediff Ecommerce
  • - Rediff HRMS
  • - Rediff CRM
  • - Rediff ERP
News
  • News
  • Business
  • Movies
  • Sports
  • Cricket
  • Get Ahead
  • Gurus
  • Astrology
  • Rediff Podcast
Stocks
  • BSE Live
  • NSE Live
  • Market News
  • Watchlist
  • Portfolio
Gurus
  • Health
  • Money
  • Career
  • Relationship
About Rediff|Advertise|Privacy Policy|Terms of Service|Investor Relations|Contact Us|© 2026 Rediff.com India Ltd. All rights reserved.